secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-10-01T21:24:17+00:00
Accession:  0001683168-26-007542
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Aethlon Medical stockholders approve charter amendments and 2020 Equity Incentive Plan increase
--------------------------------------------------------------------------------

- Stockholders approved increasing authorized common stock from 20,000,000 to 200,000,000 shares and authorizing 20,000,000 preferred shares, $0.001 par value.
- Stockholders approved adding 100,000 shares to the 2020 Equity Incentive Plan; the proposal received 204,289 votes for and 8,407 against.
- Stockholders approved issuing up to 1,126,602 common shares upon exercise of July 2026 Common Warrants and Placement Agent Warrants under Nasdaq Rule 5635(d).
- Annual Meeting held October 1, 2026; 399,752 of 711,136 shares (56.21%) represented by proxy or virtually, establishing a quorum.
- Five directors elected: Edward G. Broenniman, James B. Frakes, Nicolas Gikakis, Angela Rossetti, and Chetan S. Shah, MD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826007542/0001683168-26-007542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826007542/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer